
    
      TITLE OF STUDY:A prospective study to evaluate the safety and efficacy of LAP-BAND速
      Adjustable Gastric Band (LAGB速) operations for patients with BMI between 30-40 kg/m2 with
      co-morbidities

      CLINICAL PHASE: Phase III new indication for use of the device not yet approved by FDA

      STUDY OBJECTIVES

        -  To determine the safety and efficacy of the LAP-BAND速 Adjustable Gastric Band (LAGB速)
           for patients with BMI between 30-40 kg/m2 with co-morbidities

        -  To determine long-term effects on patients' co-morbidities

      STUDY VARIABLES: Morbidity & mortality, percent of excess weight loss, nutritional status,
      improvement of pre-operative co-morbidities, weight loss maintained, and quality of life
      evaluation

      DESIGN: Prospective single center study
    
  